Biocon's Bengaluru Facilities Clear FDA Inspection Without Issues, Shares Up 1.91% on BSE
July 27, 2024, 6:46 p.m.
The U.S. Food and Drug Administration (FDA) conducted a combined cGMP (current Good Manufacturing Practice) inspection and Pre-Licensing Inspection (PLI) at Biocon Biologics’ facilities in Bi…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.